Commercial and Corporate Litigation
Our Commercial and Corporate Litigation Practice Group represents a wide array of businesses and individuals in state and federal courts, principally in the greater New York City metropolitan area and nationwide.
We have extensive experience in complex and substantial matters involving money damages and equitable relief. We litigate disputes at the trial and appellate levels that literally encompass every area of the law. We also frequently practice before regulatory bodies and administrative agencies.
We have earned a reputation for representing our clients’ interests aggressively, successfully and in a cost-effective manner. We take pride in staffing each litigation appropriately and reasonably with a sensitivity to the cost involved in litigation.
We understand and embrace the necessity at times of aggressively litigating a matter in court. However, we also understand that providing sound pre-litigation, negotiation, counseling and settlement strategies are of equal importance to what ultimately occurs in a court room. Our attorneys excel in mediating and arbitrating disputes., Our focus always remains on the specific needs and goals of the particular client. These goals can be achieved through problem solving and creative resolution. When disputes cannot be resolved, our attorneys are well prepared to aggressively protect our client’s interests and to reach a successful conclusion to the litigation. Our litigation team includes seasoned trial and appellate attorneys, as well as numerous former prosecutors and retired judges.
Let Mandelbaum Barrett represent you in the most practical and efficient manner, for all your litigation needs.
Michael A. Saffer, Esq., of Mandelbaum Barrett Named Chairman of the Board of Trustees for Kessler Foundation
June 17, 2022
Roseland, N.J.(May 17, 2022) – Mandelbaum Barrett PC has announced that Partner Michael A. Saffer, Esq., has been named Chairman of the Board of Trustees of the Kessler Foundation. Saffer has been a member of Kessler Foundation’s Board of Trustees for four years and most recently served as Chair of the Foundation’s Research Committee for two years. Kessler Foundation researchers […]
Michael Saffer interviewed by New Jersey Law Journal regarding the biggest trends in Commercial Litigation
January 26, 2022
The likely continuing growth of the global and American economy in 2022 means that more business will be conducted and more acquisitions and consolidations of businesses will occur, according to Michael Saffer, Esq. of co-chair of Commercial and Corporate Litigation at Mandelbaum Barrett. Mr. Saffer was recently interviewed by the New Jersey Law Journal regarding the biggest trends in Commercial Litigation.
Michael Saffer Featured in Patch Article on His More Than $8M Settlements in the Past 12 Months
March 5, 2021
Mandelbaum Barrett Achieves $1.9 Million Settlement in National Overtime Class Action Against Major Telecommunications Company
October 26, 2020
Mandelbaum Barrett, PC announces that, after six years of litigation in the United States District Court for the Southern District of New York, it settled a nationwide overtime collective and a New York Rule 23 class action brought against a major telecommunications company.
Lawrence C. Weiner Co-authored a Chapter in NJICLE ‘s "Commercial Real Estate Transactions in New Jersey" Book
August 22, 2019
Congratulations to Lawrence C. Weiner, Member of the Firm's Commercial and Corporate Litigation Group, who recently co-authored a chapter in NJICLE ‘s "Commercial Real Estate Transactions in New Jersey" on "Brokerage Agreements and Related Considerations.
Mandelbaum Barrett Named to NJBIZ's 2019 Best Places to Work
March 4, 2019
We are excited and honored to announce that we have been named to NJBIZ's 2019 Best Places to Work! Whether through scholarship programs for our employees to continue their education, recognition events, health and wellness initiatives or fun team building activities, we pride ourselves on providing the best possible culture and environment for our employees.
Michael Bevacqua and Brian Block Co-authored Article for NJLJ Entitled "Insureds' Misrepresentations in Coverage Litigation Do Not Count"
February 28, 2019
Michael Bevacqua, Co-Chair of the Firm's Banking Litigation and Consumer Finance Defense Practice and Brian Block, an Associate in the group, co-authored an article for the New Jersey Law Journal entitled "Insureds' Misrepresentations in Coverage Litigation Do Not Count."
Michael Saffer Published an Article in ROI-NJ on Minimizing Attorneys' Fees and Costs
August 27, 2018
Michael Saffer, Co-Chair of Mandelbaum Barrett's Litigation Practice talks about minimizing litigation attorneys' fees and costs in an informative article for ROI-NJ. Check out what Michael has to say about ways companies and individuals can vigorously pursue and defend litigation while keeping costs down.
Michael Saffer Authors NJBiz Triple play on "3 Things to Consider When Deciding Whether to Litigate"
October 1, 2017
Michael Saffer, Member and Co-Chair of the Firm's Commercial and Corporate Litigation Practice Group was featured in an NJBiz Tripe Play yesterday on "3 Things to Consider When Deciding Whether to Litigate." Check out what Michael has to say on this important issue.
Read Associate Brian Block’s Just Published Law Review Article in the Seton Hall Circuit Review Concerning Collecting Attorney’s Fees Under the Lanham Act
February 21, 2016
The co-authored article surveys whether and how federal circuit and district courts are applying Supreme Court’s decision in Octane Fitness, LLC v. ICON Health & Fitness, Inc. (2014), which set the standard for attorneys’ fee-shifting in the Patent Act, to attorneys’ fee applications under the
Does The Coronavirus (COVID-19) Trigger The Force Majeure Clause In Your Contract?
March 23, 2020
Hopefully, it is not the “…end of the world as we know it…” as R.E.M. sang, but we are surely in uncharted waters. Indeed, as Governor Murphy has said: “It is not time for business as usual.” On March 11, 2020, the World Health Organization declared the Coronavirus, now known as COVID-19, a pandemic that […]